| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.0065 | 1 |